Novoron Bioscience Welcomes Dr. David Weiner to the Board of Directors
Novoron Bioscience is excited to announce that Dr. David Weiner is the newest member of the Board of Directors.
Novoron Bioscience To Present at BIO 2024 Conference
Novoron Bioscience, a San Diego-based biotechnology company developing first-in-class therapies to reverse central nervous system (CNS) damage, will be participating in a range of activities at the upcoming BIO 2024 conference.
Novoron Bioscience Awarded NIH Grant for Research Into Alzheimer's Disease
Novoron Bioscience has received an NIH/NIA grant to advance its work on Alzheimer’s disease, CTE and other tauopathies.
Novoron Bioscience Raises $3M in Seed Financing from Two Bear Capital
Novoron Bioscience, a San Diego-based biotechnology company developing first-in-class therapies to reverse central nervous system (CNS) damage, announced today that they secured a $3 million Seed investment from Two Bear Capital (TBC).
Novoron’s History & Milestones
Biotech company Novoron to open Missoula branch in pursuit of cure for spinal injuries
A San Diego-based biotech company this week announced its plans to expand into Missoula, where it looks to open an office and build a team in its pursuit of curing injuries to the central nervous system.
World MS Day 2020: Connecting the Multiple Sclerosis Community
A conversation focussed primarily on the importance of connecting multiple sclerosis (MS) researchers/scientists and people living with MS.
Mesenchymal Stem Cell Trial for Multiple Sclerosis
Interview with Dr. Travis Stiles and Prof. Dimitrios Karussis (Neurologist, Hadassah Hospital) about the exciting results from his mesenchymal stem cell trial for people living with multiple sclerosis.
Day 2 of the European Committee for Treatment and Research of Multiple Sclerosis Congress
Exciting stem cell trial results, progressive multiple sclerosis (MS), clinical trials, comorbidities and the treatment of symptoms were some of the key topics explored on Day 2.
Day 1 of the annual European Committee for Treatment and Research in Multiple Sclerosis
Topics covered include HSCT, remyelination, imaging and the role of environmental factors.
Novoron Bioscience - Reversing Central Nervous System Disorders + Diseases (feat. Travis Stiles)
Hear the story behind Backstage Capital Headliner Novoron Bioscience, a San Diego-based biotech company developing novel therapeutic approaches to address disorders of the central nervous system.
Novoron Bioscience Teams with Expesicor to Develop Neuroregenerative Compounds for Epilepsy and Alzheimer’s Disease
Novoron Bioscience announced a strategic partnership today with Expesicor to develop Novoron’s novel compounds to treat epilepsy and neurodegenerative disorders.
Developing Next Gen Multiple Sclerosis Therapies: Part 5
We are going to parse out myth vs. reality, explain how we address the innovation gap, and how we can improve the system to make the best possible drugs for the future.
Developing Next Gen Multiple Sclerosis Therapies: Part 4
In this article, we will discuss the different players involved in medical innovation, including their roles (and how those roles have evolved over time).
Developing Next Gen Multiple Sclerosis Therapies: Part 3
Now that we have set the stage with the drug development process, we can begin to examine possible ways to adapt the system and improve outcomes. We know that the rate of new therapies and cures has slowed, so how can we right the ship and accelerate innovation?
Developing Next Gen Multiple Sclerosis Therapies: Part 2
So how exactly does a drug come to the market?
Developing Next Gen Multiple Sclerosis Therapies: Part 1
For most people, medicine can be another language. It can be intimidating, even scary. However, modern medicine can also be miraculous and a tremendous source of hope.
Funding the Cure with Dr Travis Stiles part 2 - MS & ME Interviews
Part two of the interview with Dr. Travis Stiles in the MS & ME interview series.
Funding the Cure with Dr Travis Stiles part 1 - MS & Me Interviews
The Johnson & Johnson Under 40 to Watch List: 6 Young Trailblazing Scientists
Johnson & Johnson recently identified six young scientists working toward the next great breakthroughs in healthcare. Novoron Bioscience's CEO & President, Dr. Travis Stiles, was named one of the six.